THURSDAY, June 20, 2024 -- Reteplase is noninferior to alteplase for patients with ischemic stroke within 4.5 hours after symptom onset, according to...
Vous n'êtes pas connecté
TUESDAY, June 18, 2024 -- A multimodal intervention trial implementing evidence-based practice strategies does not reduce opioid overdose deaths, according to a study published online June 16 in the New England Journal of Medicine to coincide with...
THURSDAY, June 20, 2024 -- Reteplase is noninferior to alteplase for patients with ischemic stroke within 4.5 hours after symptom onset, according to...
WEDNESDAY, June 26, 2024 -- Tirzepatide reduces the apnea-hypopnea index (AHI) among individuals with moderate-to-severe obstructive sleep apnea and...
THURSDAY, June 27, 2024 -- For children with eosinophilic esophagitis, dupilumab results in a significantly higher percentage of histologic remission,...
THURSDAY, June 20, 2024 -- Large language model-based solutions can enhance clinical trial screening performance and reduce costs by automating the...
TUESDAY, June 25, 2024 -- Psychostimulants may help opioid use disorder (OUD) outcomes in pregnant women, according to a study published online June...
WEDNESDAY, June 26, 2024 -- Benralizumab yields a greater histologic response than placebo for patients with eosinophilic esophagitis, but does not...
MONDAY, July 1, 2024 -- A liberal transfusion strategy does not reduce the risk of unfavorable neurologic outcome at six months among critically ill...
TUESDAY, July 2, 2024 -- Psychological distress related to food allergies (FA) is common globally, according to a study published online June 21 in...
TUESDAY, June 25, 2024 -- Intermittent fasting may be a more effective intervention than drugs for people with early diabetes and either obesity or...
THURSDAY, June 20, 2024 -- Cognitive impairment is delayed among persons who are heterozygous for the apolipoprotein E3 Christchurch variant...